1 month Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks

Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.

Pharmaceuticals · Vertex (VRTX)

1 month Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks

9 hours Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Zacks

12 hours Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks

2 days Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks

2 days Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha

2 days Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks

2 days Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha

2 days Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks

4 days Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance

4 days Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance

4 days Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily

5 days Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com

5 days Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance

5 days Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha

5 days VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks

5 days Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube

5 days Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks

5 days Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study? Investor's Business Daily

5 days These Stocks Moved the Most Today: Micron, Tesla, Palantir, Quantum Computing, Lamb Weston, Accenture, Vertex, Darden, and More Yahoo Finance

6 days Vertex shares downgraded at Oppenheimer amid LSR trial uncertainties Investing.com

6 days Stocks on the Move: Vertex Pharma, Shake Shack, Zoom, Lennar and Home Depot YouTube

6 days Vertex Dives 11% On A ‘Worst-Case Scenario’ For Its Non-Opioid Pain Drug Investor's Business Daily

6 days Cramer’s Stop Trading: Vertex Pharmaceuticals YouTube

6 days Stocks to Watch Thursday: Micron, Robinhood, Vertex, Coinbase Yahoo Finance

6 days Vertex shares tumble following Phase 2 pain study results Investing.com

6 days Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily

7 days Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting Seeking Alpha

7 days REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks

7 days Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks

7 days Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks

7 days SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study Zacks

7 days Corvus Pharmaceuticals stock rebounds on positive trial results Investing.com

7 days Health AI startup Suki deliver patient summary, Q&A features for clinicians with Google Cloud CNBC

1 week Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

1 week NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

1 week 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

1 week Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks

1 week Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today Zacks

1 week BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks

1 week Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison’s Top 2 Picks Seeking Alpha

1 week Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife Seeking Alpha

2 weeks Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks

2 weeks Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue? Zacks

2 weeks Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report? Zacks

2 weeks Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable Seeking Alpha

2 weeks Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low Seeking Alpha

2 weeks Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy Seeking Alpha

2 weeks How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% Zacks

2 weeks Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks

2 weeks Tarsus Pharmaceuticals: Early Rollout Exceeding Expectations Seeking Alpha

2 weeks Here’s Why Agios Stock Plummeted More Than 20% on Monday Zacks

The Stock Market News